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The objective of this work was to elucidate if breast milk contains bifidobacteria and whether they can be
transmitted to the infant gut through breastfeeding. Twenty-three women and their respective infants provided
samples of breast milk and feces, respectively, at days 4 to 7 after birth. Gram-positive and catalase-negative
isolates from specific media with typical bifidobacterial shapes were identified to the genus level by F6PPK
(fructose-6-phosphate phosphoketolase) assays and to the species level by 16S rRNA gene sequencing.
Bifidobacterial communities in breast milk were assessed by PCR-denaturing gradient gel electrophoresis
(PCR-DGGE), and their levels were estimated by quantitative real-time PCR (qRTi-PCR). Bifidobacteria were
present in 8 milk samples and 21 fecal samples. Bifidobacterium breve, B. adolescentis, and B. bifidum were
isolated from milk samples, while infant feces also contained B. longum and B. pseudocatenulatum. PCR-DGGE
revealed the presence of one to four dominant bifidobacterial bands in 22 milk samples. Sequences with
similarities above 98% were identified as Bifidobacterium breve, B. adolescentis, B. longum, B. bifidum, and B.
dentium. Bifidobacterial DNA was detected by qRTi-PCR in the same 22 milk samples at a range between 40
and 10,000 16S rRNA gene copies per ml. In conclusion, human milk seems to be a source of living bifidobac-
teria for the infant gut.
The bacterial colonization of the infant gut is a gradual
process that exerts a strong influence on the health status of a
host, since the members of the gut microbiota may contribute
to the barrier effect against pathogens and/or to the maturation
of the intestinal immune system (4). Traditionally, it has been
considered that facultative anaerobic bacterial groups, such as
streptococci, staphylococci, enterococci, lactobacilli, or entero-
bacteria, together with some strictly anaerobic ones, especially
bifidobacteria, are among the first colonizers in breast-fed in-
fants (6). In concert, they create the condition required for the
proliferation of anaerobic bacteria, which become predomi-
nant after weaning (15). In contrast, the microbiota of formula-
fed infants seems to be more diverse and prone to changes and
contains higher counts of Bacteroides, Clostridium, and Enter-
obacteriaceae (2, 9, 10, 25, 31).
In recent years, culture-dependent and -independent analy-
ses of the bacterial diversity of human milk have revealed that
this biological fluid is a source of live staphylococci, strepto-
cocci, lactic acid bacteria, and enterobacteria for the infant gut
(11, 17, 18, 20). Bifidobacterial DNA has also been detected in
breast milk (8, 26), but to our knowledge, attempts to isolate
bifidobacteria from this source have not been successful up to
the present. Bifidobacteria are important members of the hu-
man gut microbiota and are believed to play a beneficial role in
maintaining the health of the host. They were first isolated a
century ago from infant feces and were quickly associated with
a healthy infant gut because of their predominance in breast-
fed infants in comparison to formula-fed ones (34). Since then,
it has been widely accepted that bifidobacteria represent one of
the most important bacterial groups in the infant gut. In this
location, they may contribute to the maturation of the gut
barrier and the gut-associated lymphoid tissue. Some studies
have suggested that infants with delayed bifidobacterial colo-
nization and/or decreased bifidobacterial numbers may be
more susceptible to a variety of gastrointestinal or allergic
conditions (1, 16) and that, in these cases, the exogenous ad-
ministration of selected bifidobacterial strains, alone or in
combination with lactic acid bacteria, can reduce the incidence
of such conditions (5, 13, 27, 33).
In this context, the objective of this study was the isolation
and identification of bifidobacterial strains from breast milk
and the analysis of the bifidobacterial community by molecular
methods.
MATERIALS AND METHODS
Subjects and sampling. A total of 23 women and their respective infants,
which were fed by exclusive breastfeeding, participated in the study, and they
were enrolled according to the following criteria: (i) healthy women without
present or past underlying conditions; (ii) normal, full-term pregnancy; and (iii)
absence of infant and/or maternal perinatal problems, including mastitis. None
of the subjects enrolled in this study had received a probiotic treatment during
pregnancy or after birth. All volunteers gave written informed consent to the
protocol, which was approved by the Ethical Committee of Hospital Clínico
(Madrid, Spain). The participants provided samples of breast milk, breast skin
swabs, and infant feces between days 4 and 7 after birth. The milk samples were
collected in a sterile tube by manual expression using sterile gloves. Previously,
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nipples and mammary areola had been cleaned with soap and sterile water and
soaked in chlorhexidine (Cristalmina; Salvat, Barcelona, Spain). The first drops
(500 l) were discarded. Skin sampling was performed as described previously
(24); briefly, a 4-cm2 area of the upper outer quarter of each breast was gently
rubbed using sterile cotton swabs soaked in ST solution (0.15 M NaCl with 0.1%
Tween 20). The head of each swab was aseptically cut from the handle, placed
into a microcentrifuge tube containing 100 l of ST solution, centrifuged for 5
min, and then removed. Recently, it was shown that this procedure provides a
representative profile of the microbial community of human skin (7). To detect
possible contamination, negative controls were prepared using cotton swabs in
ST solution without any contact with skin and then subjected to the above-
mentioned procedures.
All the samples were kept at 4°C until delivery to the laboratory, which
occurred within 1 h after collection.
Isolation of bifidobacteria. Proper peptone water dilutions of the milk, skin,
and fecal samples were plated in triplicate onto Man-Rogosa-Sharpe (MRS;
Oxoid, Basingstoke, United Kingdom) medium supplemented with L-cysteine
(0.5 g/liter) (MRS-Cys) agar plates, which were incubated anaerobically (85%
nitrogen, 10% hydrogen, 5% carbon dioxide) in an anaerobic workstation
(MINI-MACS; DW Scientific, Shipley, United Kingdom) at 37°C for 48 h.
Between 50 and 75 isolates from each sample were randomly selected, grown in
MRS-Cys broth, and stored at 80°C in the presence of glycerol (30%, vol/vol).
Identification of the bacterial isolates. The selected isolates were observed by
optical microscopy to determine their morphology and Gram staining results.
Additionally, they were tested for catalase, oxidase, nitrate reductase, gelatinase
activities, production of indol, and production of gas from glucose. All the
gram-positive and catalase-negative isolates with typical bifidobacterial shapes
were identified to the genus level by demonstration of fructose-6-phosphate
phosphoketolase (F6PPK) activity in cellular extracts (30) and to the species
level by PCR sequencing of a 470-bp fragment of the 16S rRNA gene, using
primers plb16 (5-AGAGTTTGATCCTGGCTCAG-3) and mlb16 (5-GGCTG
CTGGCACGTAGTTAG-3) (positions 8 to 27 and 507 to 526 in the 16S rRNA
gene sequence of Escherichia coli, respectively) (14). The PCR conditions were
as follows: 96°C for 30 s, 48°C for 30 s, and 72°C for 45 s (40 cycles) and a final
extension at 72°C for 4 min. The amplicons were purified using a Nucleospin
Extract II kit (Macherey-Nagel, Du¨ren, Germany) and sequenced at the Genom-
ics Unit of the Universidad Complutense de Madrid, Spain. The resulting se-
quences were used to search sequences deposited in the EMBL database by
using the BLAST algorithm, and the identities of the isolates were determined
on the basis of the highest scores (98%).
PCR-denaturing gradient gel electrophoresis (PCR-DGGE) and quantitative
real-time PCR (qRTi-PCR) analyses of breast milk samples. DNA was isolated
from 23 samples of breast milk collected from healthy mothers by using a
QIAamp DNA stool minikit (Qiagen, Hilden, Germany), following the manu-
facturer’s instructions. Cell lysis was further optimized by performing an addi-
tional step in which pellets were homogenized in 1.4 ml of ASL buffer (Qiagen)
with the aid of 0.1 mm zirconium beads (Biospec, Bartlesville, OK), using a
FastPrep instrument (QBioGene, Irvine, CA) for 30 s at 5,500 rpm.
Bifidobacterium genus-specific PCR was performed using 16S rRNA gene
targeting primers. To prevent a low amplicon yield, we opted for the use of a
nested PCR approach as described earlier (29). This involved a first PCR in
which primers Im3 (5-CGGGTGCTICCCACTTTCATG-3) and Im26 (5-GA
TTCTGGCTCAGGATGAACG-3) were used, followed by a second PCR with
primers Bif164-F (5-GGGTGGTAATGCCGGATG-3) and Bif662-R (5-CCA
CCGTTACACCGGGAA-3). For DGGE analysis of PCR products, a 40-bp GC
clamp was attached to the 5 end of Bif662-R. Amplification of this fragment was
successful in 22 out of 23 samples.
DGGE analysis of PCR amplicons was performed as described previously (22),
using the DCode system (Bio-Rad Laboratories, Hercules, CA). Polyacrylamide gels
consisted of 8% (vol/vol) polyacrylamide (37.5:1 acrylamide-bisacrylamide) in 0.5
Tris-acetate-EDTA. A denaturing acrylamide of 100% was defined as 7 M urea and
40% formamide. The gels were poured from the top by using a gradient maker and a
pump (Econopump; Bio-Rad, La Jolla, CA) set at a speed of 4.5 ml/min, and
gradients of 45 to 55% were used for the separation of the generated amplicons.
Immediately after the denaturing gel was poured (28-ml gradient volume), a 7.5-ml
stacking gel without denaturing chemicals was added and the appropriate comb was
inserted. Electrophoresis was performed for 16 h at 85 V with a 0.5 Tris-acetate-
EDTA buffer at a constant temperature of 60°C. Gels were stained with AgNO3
according to the method of Sanguinetti et al. (28).
PCR amplicons generated with primers Bif164-F and Bif662-R were used for
constructing clone libraries, as described previously (16). Briefly, the PCR prod-
ucts were purified with a Nucleo Spin Extract II kit (Macherey-Nagel, Du¨ren,
Germany) according to the manufacturer’s instructions and were cloned in E.
coli XL-1 blue competent cells (Stratagene, La Jolla, CA) by using a pGEM-T
easy cloning kit (Promega Corp., Madison, WI). Plasmids containing an insert of
the appropriate size were screened by DGGE analysis. Representative clones
corresponding to a specific banding position were selected for sequence analysis
at the genomic facilities of BaseClear (Leiden, The Netherlands) and Parque
Científico de Madrid (UCM, Madrid, Spain).
For qRTi-PCR assays, SYBR green PCR amplifications were performed with
an iCycler iQ real-time detection system (Bio-Rad) associated with the iCycler
Optical System Interface software program (version 2; Bio-Rad). The total
bacterial copy number was determined with primers 1369F and 1492R (32) and,
for bifidobacteria specifically, with primers Bif164F and Bif662R (26). All PCR
experiments were carried out in triplicate with a reaction volume of 25 l, using
iCycler iQ 96-well optical-grade PCR plates (Bio-Rad) covered with iCycler
optical-quality sealing film (Bio-Rad). The reaction mixture contained 2 SYBR
green PCR mixture (Bio-Rad), 0.5 M of each primer, and 5 l of either the
template or water. The amplification program consisted of 1 cycle at 95°C for 3
min and then 40 cycles at 95°C for 30 s, 62°C for 40 s, and 72°C for 1 min. The
fluorescent product was detected at the last step of each cycle. Following am-
plification, melting temperature analysis of PCR products was performed to
determine the specificity of the PCR. The melting curves were obtained by slow
heating at 0.5°C/s increments from 62 to 95°C, with continuous fluorescence
collection. For the determination of the number of bifidobacterial species
present in each sample, fluorescent signals detected from two or three serial
dilutions in the linear range of the assay were averaged and compared to a
standard curve generated with standard DNA in the same experiment. Standard
curves for all experiments were generated as follows. Bifidobacterium longum
genomic DNA was subjected to PCR using the 27F and 1492R primers. The
conditions were as follows: 95°C for 2 min; followed by 35 cycles at 95°C for 30 s,
52°C for 40 s, and 72°C for 90 s; and a final extension for 5 min at 72°C. The
amplicons were purified using DNA Clean and Concentrator-5 (ZymoResearch,
Orange, CA) according to the manufacturer’s instructions, and the yield was
quantified with a Nanodrop-1000 spectrophotometer (Nanodrop, Wilmington,
DE). The 16S rRNA gene content, expressed as numbers of copies/ml, was
calculated from the spectrophotometric results, using the average molecular
weight of a nucleotide and standard solutions serially diluted from 108 to 10 and
used in each quantitative PCR run. B. longum genomic DNA was selected to
construct the standard curve because a previous study indicated that DNA from
this species was dominant in breast milk samples (8).
Nucleotide sequence accession numbers. The sequences obtained in this study
were deposited in the GenBank database under accession numbers FJ441215 to
FJ441240.
RESULTS
Isolation and identification of bifidobacteria from breast
milk samples and infant feces. All the gram-positive and cata-
lase-negative isolates with typical bifidobacterial shapes were
identified to the genus level by the F6PPK test. In addition,
none of these isolates produced either gas from glucose or
indol, and all were negative for oxidase, nitrate reductase, and
gelatinase activities. Globally, bifidobacteria were isolated
from 8 milk samples and 21 fecal samples (Table 1), but in
contrast, they could not be isolated from any breast skin swab.
Isolates belonging to three bifidobacterial species were isolated
from milk samples: B. breve (four milk samples), B. adoles-
centis (two samples), and B. bifidum (two samples) (Fig. 1).
The species more frequently isolated from infant feces were B.
adolescentis (11 samples), B. bifidum (6 samples), B. longum (5
samples), B. breve (4 samples), and B. pseudocatenulatum (4
samples) (Table 1 and Fig. 1).
PCR-DGGE and qRTi-PCR analyses of breast milk sam-
ples. DNA isolation and subsequent PCR-DGGE analysis of
16S rRNA genes were successful for 22 out of 23 samples (Fig.
2). The samples showed between one and four dominant
bands. Sequence analysis of unique clones obtained from the
samples containing the highest levels of diversity was used for
further identification of the DGGE bands. Sequences with
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similarities above 98% were identified as Bifidobacterium breve,
B. adolescentis, B. longum, B. bifidum, and B. dentium upon
comparison with sequences of 16S rRNA genes of cultured
bacterial isolates deposited in the NCBI database. Most breast
milk samples were dominated by B. adolescentis, which was
present in 18 out of 22 samples. Sequences related to B. lon-
gum, B. bifidum, and B. breve were retrieved from 12, 8, and 4
samples, respectively. Clone j, related to B. dentium, was found
in only one sample, as was clone g, Bifidobacterium spp., which
did not reach the 98% threshold but had 97% similarity to B.
adolescentis (Fig. 1 and 2). Bifidobacterial DNA was detected
by qRTi-PCR in 22 out of 23 breast milk samples at a range
between 40 and 10,000 16S rRNA gene copies per ml (Table
2). The percentages of bifidobacterial DNA among total bac-
terial DNA were 16% (Table 2).
DISCUSSION
In recent years, breast milk has been shown to be a contin-
uous source of commensal, mutualistic, and/or probiotic bac-
teria for the infant gut, including staphylococci, streptococci,
and lactic acid bacteria (11, 20). These bacterial groups may
also play an important role in the reduction of the incidence
and severity of infections in the breast-fed infant. In fact, some
of the lactic acid bacteria strains isolated from this biological
fluid have the ability to inhibit the growth of a wide spectrum
of pathogenic bacteria by competitive exclusion and/or through
the production of antimicrobial compounds, such as bacterio-
cins, organic acids, or hydrogen peroxide (3, 21, 23).
Up to the present, the descriptions of bacterial diversity in
breast milk have been based almost exclusively on the use of
culture media that are suitable for the growth of lactic acid
bacteria, streptococci, staphylococci, and closely related gram-
positive bacteria (11, 20). This implies that the presence of
additional bacterial species that are not cultivable or difficult to
cultivate may have been overlooked. The recent application of
culture-independent molecular techniques, particularly those
based on 16S rRNA genes, has allowed a complementary as-
sessment of the biodiversity of the human milk microbiota (8,
17) and has confirmed the strong influence of this biological
fluid on the bacterial colonization of the neonatal gut (18).
However, the number of molecular microbiology studies fo-
cused on human milk is still low, and their progressive incor-
poration will open new perspectives in this field.
The results of this work confirmed that the presence of
bifidobacterial DNA is a common event in breast milk (8, 26).
In addition, this is, to our knowledge, the first report describing
the physical isolation of bifidobacteria from this biological
fluid. Bifidobacteria were isolated from only 8 of the 23 milk
samples. Among them, B. breve was isolated from the four
samples in which DNA corresponding to this species was de-
tected by PCR-DGGE and qRTi-PCR. Isolation of other
bifidobacterial species whose DNA was present in the milk sam-
ples was more difficult (B. adolescentis and B. bifidum) or even
impossible (B. longum and B. pseudocatenulatum). This may
reflect the fastidious growth requirements of some bifidobac-
terial species that could be also present in the samples and/or
their relatively low concentrations in this biological fluid. In
this context, the fact that bifidobacteria were isolated from a
higher number of infant feces samples (than from the corre-
sponding breast milk ones) may be a consequence of their
rather different concentrations (107 CFU/g in feces versus
103 CFU/ml in breast milk).
The elucidation of the origin of the bacteria present in breast





1 Milk B. adolescentis
Infant feces B. adolescentis
2 Milk
Infant feces B. adolescentis
3 Milk
Infant feces B. adolescentis
4 Milk B. adolescentis
Infant feces B. adolescentis
5 Milk
Infant feces B. adolescentis
6 Milk
Infant feces B. bifidum, B. longum
7 Milk
Infant feces B. adolescentis, B. pseudocatenulatum,
B. dentium, B. angulatum
8 Milk
Infant feces B. adolescentis, B. pseudocatenulatum
9 Milk
Infant feces B. adolescentis, B. bifidum, B. longum
10 Milk
Infant feces B. adolescentis
11 Milk B. breve
Infant feces B. breve, B. pseudocatenulatum
12 Milk
Infant feces B. adolescentis, B. longum
13 Milk B. breve
Infant feces B. breve
14 Milk
Infant feces B. longum
15 Milk
Infant feces B. dentium
16 Milk B. breve
Infant feces B. breve, B. bifidum
17 Milk B. bifidum
Infant feces B. bifidum
18 Milk B. bifidum
Infant feces B. bifidum, B. pseudocatenulatum
19 Milk
Infant feces B. adolescentis, B. bifidum
20 Milk B. breve
Infant feces B. breve
21 Milk
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milk will be an attractive research target in the future. Tradition-
ally, it was considered that they are acquired by skin contamina-
tion. Obviously, sampling of breast milk for microbiological anal-
ysis must take into account that skin contamination is almost
unavoidable and that doubts as to the original location (internal
mammary gland or skin) of the isolated bifidobacteria may arise;
however, it has been pointed out that since bifidobacteria belongs
to a strictly anaerobic genus, the latter source seems very unlikely
(8). Such observation is in accordance with the results of this study
since no bifidobacteria could be isolated from skin swabs ob-
tained from women that provided the milk samples from which
bifidobacteria were isolated. Although it has been shown that,
under certain conditions, Bifidobacterium boum and Bifidobacte-
rium thermophilum are able to grow in the presence of oxygen
(12), these species were not detected in our study. In addition,
none of the bifidobacterial isolates obtained from milk samples or
feces in this study grew in aerobic conditions. Previously, it was
reported that lactobacilli and enterococcal isolates present in hu-
man milk are genotypically different from those isolated in the
skin, within the same bacterial species and the same host (20).
The suggestions that the origin of the live bacteria found in breast
milk could be the maternal gut and that the bacteria arrive at the
mammary gland through an endogenous route (the so-called en-
tero-mammary pathway) involving maternal dendritic cells and
macrophages (19) has recently been confirmed (26). These au-
thors showed that fresh human milk contains a number (3 log
CFU/ml) of viable bacteria and a wide range of free bacterial
DNA signatures, including bifidobacterial DNA, which may pro-
gram the neonatal immune system.
In conclusion, the results of this study indicate that breast
FIG. 1. Relative abundances (percentages) of the different bifidobacterial species isolated from infant feces (A) and breast milk samples (B) or
detected in the clone library obtained from breast milk samples (C). a, B. adolescentis; b, B. longum; c, B. bifidum; d, B. breve; e, B. pseudocatenu-
latum; f, B. dentium; g, Bifidobacterium spp.
FIG. 2. Bifidobacterium species diversity in breast milk samples (lanes 1 to 22) as determined by DGGE. Dominant bands were identified as
corresponding to B. adolescentis (a), B. adolescentis (b), B. bifidum (c), B. longum (d), B. adolescentis (e), B. adolescentis (f), Bifidobacterium spp.
(97% B. adolescentis) (g), B. longum (h), B. breve (i), B. dentium (j), and B. breve (k). M1 to M4 are markers.
968 MARTI´N ET AL. APPL. ENVIRON. MICROBIOL.
milk is a source of bifidobacteria for the infant gut. Work is in
progress to characterize some of the bifidobacterial strains
isolated in this study and to further investigate the role of milk
bifidobacteria in the development of the infant gut microbiota.
ACKNOWLEDGMENTS
This study was partly supported by the FUN-C-FOOD (Consolider-
Ingenio 2010) and AGL2007-62042 projects of the Ministerio de Edu-
cacio´n y Ciencia (Spain).
REFERENCES
1. Arvola, T., T. Ruuska, J. Kera¨nen, H. Hyo¨ty, S. Salminen, and E. Isolauri.
2006. Rectal bleeding in infancy: clinical, allergological, and microbiological
examination. Pediatrics 117:e760–e768.
2. Balmer, S. E., and B. A. Wharton. 1989. Diet and faecal flora in the newborn:
breast milk and infant formula. Arch. Dis. Child. 64:1672–1677.
3. Beasley, S. S., and P. E. J. Saris. 2004. Nisin-producing Lactococcus lactis
strains isolated from human milk. Appl. Environ. Microbiol. 70:5051–5053.
4. Cebra, J. J. 1999. Influences of microbiota on intestinal immune system
development. Am. J. Clin. Nutr. 69:1046S–1051S.
5. Correa, N. B., L. A. Peret Filho, F. J. Penna, F. M. Lima, and J. R. Nicoli.
2005. A randomised formula controlled trial of Bifidobacterium lactis and
Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in
infants. J. Clin. Gastroenterol. 39:385–389.
6. Favier, C. F., W. M. De Vos, and A. D. Akkermans. 2003. Development of
bacterial and bifidobacterial communities in feces of newborn babies. Anaer-
obe 9:219–229.
7. Grice, E. A., H. H. Kong, G. Renaud, A. C. Young, G. G. Bouffard, R. W.
Blakesley, T. G. Wolfsberg, M. L. Turner, J. A. Segre, et al. 2008. A diversity
profile of the human skin microbiota. Genome Res. 18:1043–1050.
8. Gueimonde, M., K. Laitinen, S. Salminen, and E. Isolauri. 2007. Breast milk:
a source of bifidobacteria for infant gut development and maturation? Neo-
natology 92:64–66.
9. Haarman, M., and J. Knol. 2005. Quantitative real-time PCR assays to
identify and quantify fecal Bifidobacterium species in infants receiving a
prebiotic infant formula. Appl. Environ. Microbiol. 71:2318–2324.
10. Harmsen, H. J., A. C. Wildeboer-Veloo, A. A. Raangs, N. Wagendorp, J. G.
Klijn, J. G. Bindels, and G. W. Welling. 2000. Analysis of intestinal flora
development in breast-fed and formula-fed infants by using molecular iden-
tification and detection methods. J. Pediatr. Gastroenterol. Nutr. 30:61–67.
11. Heikkila¨, M. P., and P. E. J. Saris. 2003. Inhibition of Staphylococcus aureus
by the commensal bacteria of human milk. J. Appl. Microbiol. 95:471–478.
12. Kawasaki, S., T. Mimura, T. Satoh, K. Takeda, and Y. Niimura. 2006.
Response of the microaerophilic Bifidobacterium species, B. boum and B.
thermophilum, to oxygen. Appl. Environ. Microbiol. 72:6854–6858.
13. Kirjavainen, P. V., T. Arvola, S. Salminen, and E. Isolauri. 2002. Aberrant
composition of gut microbiota of allergic infants: a target for bifidobacterial
therapy at weaning? Gut 51:51–55.
14. Kullen, M. J., R. B. Sanozky-Dawes, D. C. Crowell, and T. R. Klaenhammer.
2000. Use of the DNA sequence of variable regions of the 16S rRNA gene
for rapid and accurate identification of bacteria in the Lactobacillus acidoph-
ilus complex. J. Appl. Microbiol. 89:511–516.
15. Mackie, R. I., A. Sghir, and H. R. Gaskins. 1999. Developmental microbial
ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69:1035S–
1045S.
16. Mah, K. W., B. Bjo¨rkste´n, B. W. Lee, H. P. van Bever, L. P. Shek, T. N. Tan,
Y. K. Lee, and K. Y. Chua. 2006. Distinct pattern of commensal gut micro-
biota in toddlers with eczema. Int. Arch. Allergy Immunol. 140:157–163.
17. Martín, R., H. G. Heilig, E. G. Zoetendal, E. Jime´nez, L. Ferna´ndez, H.
Smidt, and J. M. Rodríguez. 2007. Cultivation-independent assessment of
the bacterial diversity of breast milk among healthy women. Res. Microbiol.
158:31–37.
18. Martín, R., H. G. Heilig, E. G. Zoetendal, H. Smidt, and J. M. Rodríguez.
2007. Diversity of the Lactobacillus group in breast milk and vagina of
healthy women and potential role in the colonization of the infant gut.
J. Appl. Microbiol. 103:2638–2644.
19. Martín, R., S. Langa, C. Reviriego, E. Jime´nez, M. L. Marín, M. Olivares, J.
Boza, J. Jime´nez, L. Ferna´ndez, J. Xaus, and J. M. Rodríguez. 2004. The
commensal microflora of human milk: new perspectives for food bacterio-
therapy and probiotics. Trends Food Sci. Technol. 15:121–127.
20. Martín, R., S. Langa, C. Reviriego, E. Jime´nez, M. L. Marín, J. Xaus, L.
Ferna´ndez, and J. M. Rodríguez. 2003. Human milk is a source of lactic acid
bacteria for the infant gut. J. Pediatr. 143:754–758.
21. Martín, R., M. Olivares, M. L. Marín, L. Ferna´ndez, J. Xaus, and J. M.
Rodríguez. 2005. Probiotic potential of 3 lactobacilli strains isolated from
breast milk. J. Hum. Lact. 21:8–17.
22. Muyzer, G., E. C. de Waal, and G. A. Uitterlinden. 1993. Profiling of complex
populations by denaturating gradient gel electrophoresis analysis of poly-
merase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ.
Microbiol. 59:695–700.
23. Olivares, M., M. P. Díaz-Ropero, R. Martín, J. M. Rodríguez, and J. Xaus.
2006. Antimicrobial potential of four Lactobacillus strains isolated from
breast milk. J. Appl. Microbiol. 101:72–79.
24. Paulino, L. C., C. H. Tseng, B. E. Strober, and M. J. Blaser. 2006. Molecular
analysis of fungal microbiota in samples from healthy human skin and pso-
riatic lesions. J. Clin. Microbiol. 44:2933–2941.
25. Penders, J., C. Vink, C. Driessen, N. London, C. Thijs, and E. E. Stobber-
ingh. 2005. Quantification of Bifidobacterium spp., Escherichia coli and Clos-
tridium difficile in faecal samples of breast-fed and formula-fed infants by
real-time PCR. FEMS Microbiol. Lett. 243:141–147.
26. Perez, P. F., J. Dore´, M. Leclerc, F. Levenez, J. Benyacoub, P. Serrant, I.
Segura-Roggero, E. J. Schiffrin, and A. Donnet-Hughes. 2007. Bacterial
imprinting of the neonatal immune system: lessons from maternal cells?
Pediatrics 119:e724–e732.
27. Saavedra, J. M., N. A. Bauman, I. Oung, J. A. Perman, and R. H. Yolken.
1994. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to
infants in hospital for prevention of diarrhoea and shedding of rotavirus.
Lancet 344:1046–1049.
28. Sanguinetti, C. J., E. Dias Nieto, and A. J. G. Simpson. 1994. Rapid silver
staining and recovery of PCR products separated on polyacrylamide gels.
BioTechniques 17:914–921.
29. Satokari, R. M., E. E. Vaughan, A. D. L. Akkermans, M. Saarela, and W. M.
de Vos. 2001. Bifidobacterial diversity in human feces detected by genus-
specific PCR and denaturating gradient gel electrophoresis. Appl. Environ.
Microbiol. 67:504–513.
30. Scardovi, V. 1986. Genus Bifidobacterium Orla-Jensen 1924, 472AL, p. 1418–
1434. In P. H. A. Sneath, N. S. Mair, M. E. Sharpe, and J. G. Holt (ed.),
Bergey’s manual of systematic bacteriology, vol. 2. Williams and Wilkins,
Baltimore, MD.
31. Stark, P. L., and A. Lee. 1982. The microbial ecology of the large bowel of
breast-fed and formula-fed infants during the first year of life. J. Med.
Microbiol. 15:189–203.
32. Suzuki, M. T., O. Beja, L. T. Taylor, and E. F. Delong. 2001. Phylogenetic
analysis of ribosomal RNA operons from uncultivated coastal marine bac-
terioplankton. Environ. Microbiol. 3:323–331.
33. Thibault, H., C. Aubert-Jacquin, and O. Goulet. 2004. Effects of long-term
consumption of a fermented infant formula (with Bifidobacterium breve c50
and Streptococcus thermophilus 065) on acute diarrhea in healthy infants.
J. Pediatr. Gastroenterol. Nutr. 39:147–152.
34. Tissier, H. 1906. Traitement des infections intestinales par la me´thode de la
flore bacte´rienne de l’intestin. C. R. Soc. Biol. 60:359–361.
TABLE 2. Counts of bacteria and bifidobacteria in breast milk








1 1.14E  05 4.04E  03 3.54
2 4.04E  05 1.16E  04 2.87
3 2.08E  05 1.08E  04 5.19
4 1.48E  05 9.40E  03 6.35
5 1.43E  05 5.20E  03 3.64
6 1.17E  05 1.04E  02 0.09
7 9.00E  07 8.68E  02 0.00
8 2.48E  05 6.88E  03 2.77
9 2.40E  02 0.00E  00 0.00
10 1.08E  05 3.15E  03 2.92
11 4.56E  04 7.32E  03 16.05
12 7.72E  04 2.01E  03 2.60
13 6.68E  04 5.04E  03 7.54
14 1.25E  05 2.13E  02 0.17
15 1.36E  05 4.32E  01 0.03
16 1.61E  05 1.00E  03 0.62
17 8.40E  06 9.36E  02 0.01
18 1.16E  05 6.00E  02 0.52
19 1.27E  05 1.74E  03 1.37
20 2.25E  05 1.72E  02 0.08
21 1.20E  05 1.50E  02 0.13
22 4.44E  04 2.42E  03 5.45
Mean 4.60E  06 3.35E  03 2.82
a Expressed as the number of copies of the 16S rRNA gene.
b Bifidobacterial load expressed as the percentage of total bacteria.
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